Ha Tay Pharmaceutical JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DHT3
VND
68,800.00
-13200 (-16.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
DHG Pharmaceutical JSC
Mediplantex National Pharmaceutical JSC
OPC Pharmaceutical JSC
Domesco Medical Import-Export JSC
Binh Dinh Pharmaceutical & Medical Equipment JSC
F.I.T. Investment JSC
Ben Tre Pharmaceutical JSC
Imexpharm Corp.
Ha Tay Pharmaceutical JSC
Cuu Long Pharmaceutical JSC
Mekophar Chemical Pharmaceutical JSC

Why is Ha Tay Pharmaceutical JSC ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.06%
EBIT Growth (5y)
-11.07%
EBIT to Interest (avg)
5.19
Debt to EBITDA (avg)
1.37
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
1.44
Tax Ratio
20.78%
Dividend Payout Ratio
57.36%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.86%
ROE (avg)
13.65%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
90
Industry P/E
Price to Book Value
6.57
EV to EBIT
100.54
EV to EBITDA
77.20
EV to Capital Employed
5.71
EV to Sales
3.33
PEG Ratio
8.06
Dividend Yield
0.53%
ROCE (Latest)
5.68%
ROE (Latest)
7.33%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
DEBT-EQUITY RATIO (HY)

Lowest at 9.12 %

DEBTORS TURNOVER RATIO(HY)

Highest at 17.93 times

NET SALES(Q)

Highest at VND 692,879.69 MM

-25What is not working for the Company
ROCE(HY)

Lowest at 5.08%

INTEREST COVERAGE RATIO(Q)

Lowest at 127.34

OPERATING PROFIT(Q)

Lowest at VND 3,512.18 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 0.51 %

RAW MATERIAL COST(Y)

Grown by 38.4% (YoY

PRE-TAX PROFIT(Q)

Lowest at VND 13,560.79 MM

NET PROFIT(Q)

Lowest at VND 6,162.08 MM

EPS(Q)

Lowest at VND 0

Here's what is working for Ha Tay Pharmaceutical JSC

Net Sales
Highest at VND 692,879.69 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (VND MM)

Net Sales
At VND 692,879.69 MM has Grown at 23.09%
over average net sales of the previous four periods of VND 562,895.9 MM
MOJO Watch
Near term sales trend is positive

Net Sales (VND MM)

Debt-Equity Ratio
Lowest at 9.12 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 17.93 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Ha Tay Pharmaceutical JSC

Net Profit
At VND 6,162.08 MM has Fallen at -62.97%
over average net sales of the previous four periods of VND 16,642.41 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (VND MM)

Interest Coverage Ratio
Lowest at 127.34
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit
Lowest at VND 3,512.18 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (VND MM)

Operating Profit Margin
Lowest at 0.51 % and Fallen
In each period in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
At VND 13,560.79 MM has Fallen at -37.69%
over average net sales of the previous four periods of VND 21,763.03 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (VND MM)

Pre-Tax Profit
Lowest at VND 13,560.79 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (VND MM)

Net Profit
Lowest at VND 6,162.08 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (VND MM)

EPS
Lowest at VND 0
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (VND)

Raw Material Cost
Grown by 38.4% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at VND 0.94 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income